LeapZipBlog: Mike Williams's blog: Biosimilars Market in India Market Analysis, Growth and Opportunities 2017

Biosimilars Market in India Market Analysis, Growth and Opportunities 2017

February 2, 2019 by Mike Williams  

Netscribes latest market research report titled Biosimilars Market in India 2017, describes the current and forecasted dynamics of the biosimilars market in India. The increasing incidence of diseases such as CVD and CHD, cancer and diabetes has led to an increase in the demand for these products and has resulted in the growth of this industry in India. Biosimilars are typically marketed at prices that are 25% to 40% below the prices of original branded products. This has been the primary appeal to customers. Moreover, the rise in the number and quality of tertiary care centers is resulting in the greater usage of these products. Rising drug costs, limited healthcare budgets across the world and patent expiries of biotechnology drugs have created a huge opportunity for biosimilar manufacturers. There aren't too many players in the market and the industry is dominated by a small number of sellers leaving a room for the new entrants in the market. 

Request for Sample Report @ https://www.kdmarketresearch.com/sample/1903

However, required capital investment and operating costs for manufacturing is much higher for biosimilars than for generic drugs. The process to develop a generic version of biosimilar is also complex than developing a generic copy of a chemical-based compound. Extensive funding is required due to emerging rigorous regulatory requirements which act as a challenge for the players in the industry. Lack of widespread awareness towards the biosimilar products is also acting as a drawback for the industry as people tend to avoid using biosimilar products. The stringent regulatory framework of the healthcare industry which requires biosimilars to undergo several regulatory measures is cumbersome for companies looking to constantly innovate and launch new products in the market. Although there are challenges in the industry, the market for biosimilars is expected to grow with more players entering the market and development of new biosimilar products for the treatment of chronic diseases.

Public Companies

1. Biocon Limited 
2. Dr. Reddy's Laboratories Limited
3. Lupin Limited
4. Cipla Limited
5. Zenotech Laboratories Limited
6. Wockhardt Limited

Private Companies

1. Intas Pharmaceuticals Limited
2. Bharat Biotech Limited
3. Reliance Life Sciences Private Limited
4. Shantha Biotechnics Private Limited

Slide 1: Executive Summary

Browse Complete Report with Full TOC@ https://www.kdmarketresearch.com/report/biosimilars-market

Socioeconomic Indicators

Slide 2: Total Population (2010-2011 – 2019-2020), Population Density (2010-2011 – 2019-2020)
Slide 3: Sex Ratio (2005, 2010, 2015, 2020), Population by Age Group (2005, 2010, 2015, 2020), Urbanization Trend (2010-2011 – 2019-2020)
Slide 4: Total Fertility Rate (2005-2010, 2010-2015, 2015-2020), Infant Mortality Rate (2005-2010, 2010-2015, 2015-2020), Total Number of Births (2005-2010, 2010-2015, 2015-2020), Total Number of Death (2005-2010, 2010-2015, 2015-2020)
Slide 5: Total Literacy Rate (2001, 2011), Rural Literacy (2001, 2011), Urban Literacy (2001, 2011)
Slide 6: GDP at Market Prices (2010-2014), FDI (2010-2014), Inflation Rate (2010-2014), Unemployment Rate (2010-2014)
Slide 7: Access to Safe Drinking Water (2001, 2011), Exchange Rate (2010-2015)
 
Market Overview
Slide 8: Market Definition and Structure
Slide 9: Biosimilars Market in India – Overview, Size and Growth (Value-Wise, 2011 – 2020e)
Slide 10: Regulatory Bodies and Guidelines

Market Opportunity
Slide 11: Future Growth Opportunities for the Market

Market Influencers
Slide 12: Market Drivers
Slide 13: Market Challenges

Competitive Landscape
Slide 14: List of Major Players
Slide 15-36: Profiles of Major Players

Recent Developments 
Slide 37-42: Key Recent Developments

Appendix
Slide 43: Research Methodology

For more info @@

Make inquiry about this report @ https://www.kdmarketresearch.com/enquiry/1903

About KD Market Research

KD Market Research is one of the best market research organization that provides B2B research on the growth opportunities of the industry which is the prime factor of the overall revenue of the organization. We identify the pain points which our client is facing around revenue methods and provide them with a comprehensive database which helps them to make intelligent decisions that could ensure growth to the organization.

Our Services include market intelligence, competitive intelligence, and customized research. These research reports help the organizations to make quick and powerful decisions that make out highest growth in revenue.

 

Contact Us

150th State Street,

 Albany, NY, USA, 12207

Phone number: - +1 (518) 300-1218

Email: - sales@kdmarketresearch.com

Website: – http://www.kdmarketresearch.com/